Interim Report 2026
Filed with HKEX · Stock code 8189 · · 25 pages · English
GEM has been positioned as a market designed to accommodate small and mid-sized companies to which a higher investment risk may be attached than other companies listed on the Stock Exchange. Prospective investors should be aware of the potential risks of investing in such companies and should make the decision to invest only after due and careful consideration. Given that the companies listed on G
Tianjin TEDA Biomedical Engineering Co. Ltd. on 6ix
Earlier from Tianjin TEDA Biomedical Engineering
- Change of principal place of business in hong kong
- Tianjin Teda Biomedical Engineering Enters Strategic Cooperation Agreement
Later from Tianjin TEDA Biomedical Engineering
- Poll results of the extraordinary general meeting
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
Follow Tianjin TEDA Biomedical Engineering into a list and get an email when it puts out news.
Follow Tianjin TEDA Biomedical Engineering